OpenLegislation

Part 8 Transitional provision in respect of homoeopathic medicinal productsF1

  1. 43List of countries for the purposes of the definition of “homoeopathic medicinal product” on IP completion day
  2. 44Place of establishment for holders of certificates of registration established in EEA before IP completion day
  3. 45Temporary exemption as to packaging requirements: change of place of establishment
  4. 46Applications made for a certificate of registration for a registrable homoeopathic product before IP completion day to which Chapter 4 of Title III of the 2001 Directive applied
  5. 47Suspensions of certificates of registration that have effect immediately before IP completion day that were imposed under Chapter 4 of Title III of the 2001 Directive
  6. 48Referrals made under Article 31 of the 2001 Directive concerning the suspension, variation or revocation of a certificate of registration that have not concluded before IP completion day

Annotations

Textual amendments

F1

Sch. 33A inserted (31.12.2020) by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/775), reg. 1, Sch. 7 (as amended by S.I. 2020/1488, reg. 1, Sch. 2 para. 193); 2020 c. 1, Sch. 5 para. 1(1)